Literature DB >> 7979514

Use of enteric coated prednisolone in Crohn's disease.

R M Beattie, J A Walker-Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7979514      PMCID： PMC1029995          DOI： 10.1136/adc.71.3.282-a

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  4 in total

1.  Absorption of enteric and non-enteric coated prednisolone tablets.

Authors:  B Hulme; V H James; R Rault
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

2.  Plasma prednisolone levels in man following administration in plain and enteric-coated forms.

Authors:  C G Wilson; C S May; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

3.  Malabsorption of prednisolone from enteric-coated tablets after ileostomy.

Authors:  S Al-Habet; H C Kinsella; H J Rogers; J R Trounce
Journal:  Br Med J       Date:  1980-09-27

4.  Absorption of prednisolone in patients with Crohn's disease.

Authors:  J A Shaffer; S E Williams; L A Turnberg; J B Houston; M Rowland
Journal:  Gut       Date:  1983-03       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.